previous

CEA Method: ECLIA, Roche (Serum (s))

Specimens: 500 µl Serum (s)
Preanalytics/Notes:
  • In patients receiving therapy with high biotin doses (i.e. > 5 mg/day) no sample should be taken until at least 8 hours after the last biotin administration, as high dosis biotin application might disturbe the assay.
  • Please note: results obtained using different methods and/or test manufacturers cannot be compared with one another. The course of tumor markers should always be assessed by the same test.
Method: ECLIA
Dimension: ng/ml
Set-up: Mon Tue Wed Thu Fri Sat Sun
Duration: 1 day
Indication/Significance:

Tumour marker for carcinomas of the gastro-intestinal tract (colon, oesophagus, stomach) as well as of the mamma, bronchial system, uterus and cervix:

  • Pre-operative or pre-therapeutic in the case of the initial diagnosis of the above mentioned carcinomas
  • For the differential-diagnostic clarification together with other tumour markers in the case of unclear round liver lesions or unclear pulmonary masses
  • Together with calcitonin in the case of familial predisposition with regard to the C-cell carcinoma
  • Monitoring of the progress of all above mentioned carcinomas
Interpretation:
Further tests: Further tumour markers, e.g. CA 19-9, CA 15-3 inter alia

performance by Bioscientia medical service centers​

Reference range / valuation (openclose)

initial letter


Abrechnung GOÄ

Die Kosten werden für den i. d. R. genutzten 1,15-fachen GOÄ-Satz dargestellt. Wird die Unter­suchung nicht in Ihrem regionalen Labor durch­geführt, erfolgt die Analyse in dem Labor, das im Leistungs­ver­zeich­nis genannt ist. In diesem Fall gilt der dort für die Untersuchung angegebene Preis.